Document is current

Any future updates will be listed below

Dose- and Formulation-Dependent Non-Linear Pharmacokinetic Model of Paritaprevir, a Protease Inhibitor for the Treatment of Hepatitis C Virus Infection: Combined Analysis from 12 Phase I Studies

Crossref DOI link: https://doi.org/10.1007/s40262-016-0385-4

Published Online: 2016-03-21

Published Print: 2016-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark